David Gibson > McDermott Will & Emery UK LLP > London, England > Lawyer Profile
McDermott Will & Emery UK LLP Offices
22 Bishopsgate
London
EC2N 4BQ
England
- Firm Profile
- Go to...
David Gibson
Work Department
Healthcare
Position
David is an associate, he focuses his practice on commercial health care, with a background in providing commercial, corporate and financial advice to health care clients. His areas of specialty include procurement, outsourcing and “insourcing” of clinical and non-clinical health care services, private patient services, health care regulatory, advice on medical device regulations as well as leading specialist projects, such as the NHS Proton Beam project.
Visit our website for more: https://www.mwe.com/people/gibson-david/
Education
University of Bristol, LLM, 1997
University of Exeter, LLB, 1996
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
(Leading associates)Lauded for advice that ‘balances the risks and benefits of any given approach clearly’, McDermott Will & Emery UK LLP is active across regulatory matters such as medical device certifications and transactional work spanning M&A, IP transfers and growth capital investments. Sharon Lamb heads up the team and has a far-reaching practice spanning commercial, regulatory and transactional expertise. Hamid Yunis is a key contact for private equity transactions. Michal Berkner, who joined from Cooley (UK) LLP in February 2024, further bolsters the team’s transactional capacities and counts takeover defences, corporate governance, and joint ventures among her practice strengths. David Gibson and Bella North are further key names to note.
Lawyer Rankings
- Leading associates London > Industry focus > Life sciences and healthcare
- Life sciences and healthcare London > Industry focus
Top Tier Firm Rankings
- Real estate > Commercial property: investment
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
Firm Rankings
- Dispute resolution > Commercial litigation: mid-market
- Private client > Contentious trusts and probate
- Finance > Debt capital markets
- Industry focus > Emerging markets
- Industry focus > Life sciences and healthcare
- Corporate and commercial > M&A: Lower Mid-Market Deals, £100m-£750m
- Private client > Personal tax, trusts and probate
- Finance > Acquisition finance
- Finance > Derivatives and structured products
- Risk advisory > ESG
- Finance > High yield
- Dispute resolution > International arbitration
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £500m)
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Finance > Bank lending: investment grade debt and syndicated loans
- Finance > Corporate restructuring & insolvency
- Corporate and commercial > Corporate tax
- Real estate > Property finance
- Projects, energy and natural resources > Renewables
- Employment > Employers